Linked Data API

Show Search Form

Search Results

1123848
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Haematological Cancer: Screening more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what his timetable is for whole genome sequencing to be made available to patients with blood cancer; and what assessment he has made of the potential benefits of that sequencing for those patients' care. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 249261 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-09more like thismore than 2019-05-09
star this property answer text <p>Up to 50% of cancer patients enrolled in the 100,000 genomes project, including patients with blood cancer, have seen a change in their treatment since receiving their result. This could be eligibility for a new trial, or prescription of a new medicine.</p><p>The National Genomic Test Directory outlines the range of genomic tests – from whole genomic sequencing to tests for single genes and molecular markers – that are available as part of the National Health Service clinical service.</p><p>From summer 2019, whole genome sequencing will be implemented as part of routine clinical care and be available to:</p><p>- Seriously ill children with a suspected genetic disorder, including those with cancer;</p><p>- People with one of 21 rare and inherited conditions; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using whole genome sequencing – children with cancer, sarcoma and acute myeloid leukaemia.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-05-09T14:31:31.08Zmore like thismore than 2019-05-09T14:31:31.08Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this